Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Funding
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By
LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
National Cancer Institute launches network to evaluate cancer screening technologies
By
LabPulse.com staff writers
In support of the Biden-Harris administration’s Cancer Moonshot initiative, the U.S. National Institutes of Health has launched the Cancer Screening Research Network, a clinical trial network for evaluating emerging cancer screening technologies.
February 22, 2024
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
By
LabPulse.com staff writers
CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect
Neisseria gonorrhoeae
, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.
February 8, 2024
$2.4M NIH Wadsworth lab grant supports more exposome studies
By
LabPulse.com staff writers
The NIH has awarded the Wadsworth Center Health Exposure Analysis Research (HHEAR) laboratory hub $2.4 million to continue studies of the exposome.
December 15, 2023
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
By
LabPulse.com staff writers
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases
By
Matt Limb
U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.
September 14, 2023
NIH awarding $50.3M to establish multiomics consortium
By
LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.
September 14, 2023
Actome outlines sequencing expansion plans as EU funding kicks in
By
Nick Paul Taylor
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Day Zero Diagnostics awarded SBIR grant to develop fecal transplant safety assay
By
Matt Limb
Boston-based Day Zero Diagnostics is receiving research funding to support the development of a pharmacovigilance assay to enhance the safety and efficacy of fecal microbiota transplants (FMT) in clinical trials.
September 1, 2023
Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests
By
Matt Limb
Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.
July 26, 2023
CellChorus awarded two grants to accelerate single-cell analysis platform
By
LabPulse.com staff writers
The grants will be used to accelerate the development of CellChorus’ Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) platform for single-cell analysis.
June 30, 2023
Consortium nabs $10M European grant to develop drug response tests for CKD
By
LabPulse.com staff writers
The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.
January 26, 2023
Page 1 of 4
Next Page